FDA Inspection 1035875 — Apotex, Inc.
The FDA completed an inspection of Apotex, Inc. on Dec 8, 2017 in Etobicoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Etobicoke (Canada)